Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation

Published:2010-03-01 Issue:2 Volume:10 Page:176-191
ISSN:1568-0096
Container-title:Current Cancer Drug Targets
language:en
Short-container-title:CCDT

Author:

E. Favoni R.,Pattarozzi A.,Casto M.,Barbieri F.,Gatti M.,Paleari L.,Bajetto A.,Porcile C.,Gaudino G.,Mutti L.,Corte G.,Florio T.,Casto M.

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Drug Discovery,Pharmacology,Oncology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond;World Journal of Gastroenterology;2023-03-07

2. Role of thyroid hormone-integrin αvβ3-signal and therapeutic strategies in colorectal cancers;Journal of Biomedical Science;2021-04-08

3. Synergistic Effect of Laminin and Epidermal Growth Factor on Biological and Morphological Properties of Co-Cultured Myoblasts and Fibroblasts;Tissue Engineering and Regenerative Medicine;2020-08-06

4. Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells;Current Cancer Drug Targets;2019-12-23

5. Precision engineering of targeted nanocarriers;WIREs Nanomedicine and Nanobiotechnology;2018-02-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP